Global Bromelain Market Report By Product Type (Stem Bromelain, Fruit Bromelain), By Form (Powder, Liquid), By Application (Healthcare, Food & Beverage, Dietary Supplements, Cosmetics & Personal Care, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: June 2024
- Report ID: 122526
- Number of Pages: 340
- Format:
- keyboard_arrow_up
Quick Navigation
Report Overview
The Global Bromelain Market size is expected to be worth around USD 63.9 Million by 2033, from USD 34.7 Million in 2023, growing at a CAGR of 6.3% during the forecast period from 2024 to 2033.
The Bromelain market involves the production and distribution of bromelain, an enzyme extracted from pineapples. Bromelain is used in the food and beverage, pharmaceutical, and cosmetic industries for its anti-inflammatory and digestive properties. The market is driven by the rising demand for natural health supplements and functional foods.
Key participants include enzyme manufacturers, food processors, and pharmaceutical companies. Trends show growth due to increasing consumer preference for natural and organic products and ongoing research into new applications for bromelain.
The bromelain market is poised for significant growth, driven by increasing awareness and prevalence of digestive health issues. According to the National Institutes of Health, approximately 60-70 million individuals in the United States suffer from digestive diseases.
This encompasses a wide range of conditions, including gastrointestinal infections, with 135 million cases, and prevalent issues like hemorrhoids, affecting 75% of individuals over 45 years. Additionally, chronic inflammatory conditions such as Crohn’s disease and ulcerative colitis account for nearly 978,000 cases. These statistics highlight a substantial demand for effective digestive health solutions.
Furthermore, the digestive disorder prevalence extends beyond the United States, with over 332 million people affected across the European region as per a report from United European Gastroenterology. This widespread prevalence underscores a robust market potential for digestive enzymes like bromelain. Bromelain, derived from pineapple stems, is renowned for its anti-inflammatory and digestive benefits, making it a prime candidate for addressing these health issues.
Market dynamics indicate a growing inclination towards natural and holistic health solutions, which further catalyzes the demand for bromelain. The enzyme’s therapeutic properties, coupled with a heightened consumer focus on safe and natural treatments, are expected to drive its adoption in dietary supplements and pharmaceuticals.
As health professionals and consumers continue to recognize bromelain’s benefits, its market is likely to see substantial growth, reflecting a broader trend towards natural health products. This trend presents significant opportunities for investors and companies within the nutraceutical industry to capitalize on the expanding market landscape.
Key Takeaways
- Market Value: The Bromelain Market was valued at USD 34.7 million in 2023, and is expected to reach USD 63.9 million by 2033, with a CAGR of 6.3%.
- Product Type Analysis: Stem Bromelain dominated with 65.9%; important for its higher enzyme activity and applications.
- Form Analysis: Powder form led with 55.6%; significant for its stability and ease of use in various applications.
- Application Analysis: Food & Beverage dominated with 43.6%; crucial for its use in tenderizing and digestive aids.
- Dominant Region: North America held 35.6%; significant due to high demand in food and healthcare industries.
- Analyst Viewpoint: The bromelain market is moderately competitive with steady demand in food, healthcare, and cosmetics sectors. Future trends indicate increased use in dietary supplements and natural health products.
- Growth Opportunities: Companies can focus on expanding applications in health and wellness products, improving production processes, and exploring new markets to differentiate themselves.
Driving Factors
Growing Awareness of Natural Health Supplements Drives Market Growth
Increasing consumer awareness of natural health supplements significantly propels the Bromelain market. As more individuals seek natural and plant-based alternatives to synthetic drugs, Bromelain, derived from pineapple stems, has gained considerable traction. This enzyme is celebrated for its anti-inflammatory and digestive health benefits, making it an attractive option for health-conscious consumers. For example, Nature’s Way has effectively marketed its Bromelain products as natural remedies for joint pain and digestive issues, leveraging this trend.
The rising preference for natural supplements is further supported by a broader consumer movement towards organic and clean-label products. This shift is expected to continue, bolstering the Bromelain market’s growth. The global market for dietary supplements size is expected to be worth around USD 306 billion by 2033, from USD 156 billion in 2023.
Rising Prevalence of Digestive Disorders Drives Market Growth
The increasing prevalence of digestive disorders worldwide is a significant driver of the Bromelain market. Changes in lifestyles and dietary habits have led to a surge in digestive health issues. Bromelain’s efficacy in breaking down proteins and aiding digestion has made it a popular supplement for addressing these problems. NOW Foods’ Super Enzymes, which includes Bromelain, exemplifies this trend, having seen a marked increase in sales among consumers with digestive complaints.
The growing number of individuals seeking effective digestive health solutions highlights the critical role of Bromelain in this market. According to recent studies, approximately 20% of the global population suffers from chronic digestive disorders, underscoring the substantial demand for effective treatments like Bromelain. This increasing consumer base is expected to drive continued growth in the market.
Expanding Applications in the Food Industry Drive Market Growth
Bromelain’s expanding applications in the food industry are another crucial factor driving its market growth. Known for its meat-tenderizing properties, Bromelain is increasingly used in food processing to soften meat, reduce cooking time, and improve texture. McCormick & Company, for instance, has introduced a meat tenderizer featuring Bromelain as a key ingredient, which has gained significant traction among both restaurants and home cooks.
The enzyme’s ability to enhance food quality and preparation efficiency makes it highly valuable to the food industry. The global processed meat market is expected to grow at a CAGR of 4.8% from 2022 to 2033, indicating a growing demand for food processing aids like Bromelain. This trend, combined with the increasing consumer preference for high-quality food products, underscores the enzyme’s expanding role and its positive impact on market growth.
Restraining Factors
Limited Awareness in Developing Markets Restrains Market Growth
Limited awareness of Bromelain in developing markets significantly hinders its growth. In many developing countries, people are not familiar with Bromelain and its benefits. This lack of awareness prevents widespread adoption and market expansion. For instance, in rural India, traditional remedies are preferred over supplements like Bromelain.
A survey revealed that only a small percentage of the population has heard of Bromelain. This gap in knowledge restricts potential market penetration. Without targeted educational campaigns and increased marketing efforts, Bromelain’s growth in these regions will remain slow.
Stringent Regulatory Frameworks Restrain Market Growth
Stringent regulatory frameworks around dietary supplements and food additives pose significant challenges for Bromelain manufacturers. These regulations vary globally, making it difficult for companies to operate efficiently. In the European Union, for example, manufacturers must comply with the Novel Food Regulation to market Bromelain products.
This process can be both time-consuming and costly. A European enzyme manufacturer reported that navigating these regulations significantly delayed their product launch, increasing costs. Such regulatory hurdles can deter new entrants and limit the market growth of Bromelain. Overcoming these challenges requires substantial investment and strategic planning, which can be a major restraint for the market.
Product Type Analysis
Stem Bromelain dominates with 65.9% due to its higher enzymatic activity and broader application range.
The Bromelain market is primarily segmented by product type into Stem Bromelain and Fruit Bromelain. Stem Bromelain, derived from the pineapple stem, holds the majority share in the market. This dominance is due to its higher enzymatic activity compared to fruit Bromelain, making it more effective in various applications.
Stem Bromelain is extensively used in the healthcare sector for its anti-inflammatory and digestive benefits. It is also popular in the food and beverage industry for meat tenderization and protein hydrolysis. The demand for Stem Bromelain is further boosted by its efficacy in wound healing and as a component in dietary supplements. These factors collectively drive the growth of Stem Bromelain in the market, securing its leading position.
On the other hand, Fruit Bromelain, obtained from the pineapple fruit, plays a significant role but does not match the wide application and effectiveness of Stem Bromelain. Fruit Bromelain is primarily used in the food industry for its meat tenderizing properties and in cosmetics for its skin exfoliating benefits. While it is valued for these uses, its market share remains lower due to the superior enzymatic profile of Stem Bromelain.
Form Analysis
Powder dominates with 55.6% due to its ease of handling, stability, and versatility.
The market for Bromelain is segmented by form into powder and liquid. Bromelain in powder form is preferred across various industries, making up the largest share of the market. The powdered form of Bromelain is more stable and has a longer shelf life, which is crucial for both manufacturers and consumers.
Its ease of handling and incorporation into different products enhances its appeal. In the food and beverage industry, powdered Bromelain is extensively used for meat tenderization and protein hydrolysis. In the healthcare and dietary supplement sectors, its stability and ease of dosage formulation make it a favored choice. These attributes significantly contribute to the dominance of powdered Bromelain in the market.
Liquid Bromelain, while effective, is less stable and has a shorter shelf life compared to its powdered counterpart. This limits its use primarily to specific applications where liquid form is necessary, such as in certain medical formulations and cosmetic products. Although liquid Bromelain is beneficial in these niches, its overall market share is lower due to the handling and storage advantages of the powder form.
Application Analysis
Food & Beverage dominates with 43.6% due to its extensive use in meat tenderization and protein hydrolysis.
The Bromelain market is segmented by application into healthcare, food & beverage, dietary supplements, cosmetics & personal care, and others. The food and beverage industry is the largest application segment for Bromelain, primarily due to its extensive use in meat tenderization. Bromelain’s ability to break down protein structures makes it invaluable for improving meat texture and reducing cooking times, which is highly beneficial for both commercial food processors and home cooks.
Additionally, Bromelain is used in brewing processes and as a dietary supplement in various food products, further driving its demand in this segment. The growing consumer preference for high-quality and easily digestible food products boosts the application of Bromelain in the food and beverage industry, securing its leading position.
Healthcare and dietary supplements are also significant application areas for Bromelain. In healthcare, Bromelain is valued for its anti-inflammatory and digestive properties, making it a popular choice for treating conditions like arthritis and digestive disorders. Dietary supplements containing Bromelain are widely consumed for their health benefits, further contributing to the growth of this segment. While these applications are important, their market share is lower compared to the food and beverage sector due to the more specific and targeted use cases.
Cosmetics and personal care products also utilize Bromelain, particularly for its exfoliating properties. It is incorporated into skincare products to enhance skin texture and remove dead skin cells. Although this segment is growing, its market share remains smaller due to the niche nature of these applications.
Key Market Segments
Product Type
- Stem Bromelain
- Fruit Bromelain
Form
- Powder
- Liquid
Application
- Healthcare
- Food & Beverage
- Dietary Supplements
- Cosmetics & Personal Care
- Others
Growth Opportunities
E-commerce Expansion Offers Growth Opportunity
The rise of e-commerce platforms presents significant growth opportunities for Bromelain products. Online retail allows companies to reach a broader audience and directly educate consumers about Bromelain’s benefits. iHerb, an online health store, reported a 30% increase in Bromelain supplement sales after implementing targeted digital marketing campaigns.
This indicates the potential for increased sales and market penetration through online channels. E-commerce also provides a convenient shopping experience, appealing to health-conscious consumers who prefer to purchase supplements online. The expanding online retail space is set to drive further growth in the Bromelain market by making it more accessible to a global audience.
Sports Nutrition Market Offers Growth Opportunity
The growing sports nutrition market presents a valuable opportunity for Bromelain. Its anti-inflammatory properties make it an ideal ingredient for post-workout recovery supplements. Myprotein, a leading sports nutrition brand, introduced a Bromelain-infused recovery formula, which quickly gained popularity among fitness enthusiasts.
This trend highlights the potential for Bromelain to be marketed as a key component in sports nutrition products. As more consumers engage in fitness activities and seek effective recovery solutions, the demand for Bromelain-based supplements is expected to rise, driving market growth.
Trending Factors
Clean Label Trend Are Trending Factors
The clean label trend is a significant driver in the Bromelain market. Consumers increasingly demand transparency in product ingredients, seeking natural and simple formulations. Bromelain, being a natural enzyme, aligns perfectly with this trend. Garden of Life, an organic supplement company, prominently features “100% natural Bromelain” on their product labels, catering to this consumer preference.
This emphasis on natural ingredients boosts consumer trust and drives sales. As the clean label trend continues to gain momentum, Bromelain’s market presence is expected to strengthen, leveraging its natural and health-promoting qualities to attract a growing base of health-conscious consumers.
Personalized Nutrition Are Trending Factors
The shift towards personalized nutrition is another trending factor that benefits the Bromelain market. Consumers are increasingly seeking customized health solutions tailored to their specific needs. Companies like Care/of offer personalized supplement plans that include Bromelain for individuals with specific digestive or inflammatory issues.
This personalized approach enhances consumer engagement and satisfaction. As more consumers adopt personalized nutrition regimes, the demand for targeted supplements like Bromelain is set to increase. This trend underscores the growing importance of customization in the supplement market and highlights Bromelain’s role in addressing specific health concerns.
Regional Analysis
North America Dominates with 35.6% Market Share
North America leads the Bromelain market with a 35.6% market share, valued at USD 12.3 million.
Several factors drive North America’s dominance. High consumer awareness of health supplements, widespread acceptance of natural health products, and advanced healthcare infrastructure boost Bromelain demand. Leading companies like Nature’s Way and NOW Foods, based in the U.S., further strengthen the market. The region’s focus on health and wellness trends also plays a crucial role.
Regional characteristics like high disposable income and a well-established e-commerce sector enhance market performance. The robust supply chain and distribution networks ensure product availability. Regulatory support for dietary supplements also encourages market growth.
North America’s influence is expected to remain strong. The market is likely to see steady growth as health trends continue to rise. Innovations in product formulations and increased marketing efforts will further boost Bromelain’s market presence.
Market Share in Other Regions
- Europe: Europe holds a significant market share of 25.4%. The demand for natural health products and stringent quality standards drive market growth. The presence of major players and growing consumer health consciousness support this share.
- Asia Pacific: Asia Pacific accounts for 20.7% of the market share. Rising health awareness, increasing disposable income, and the expanding middle class contribute to market growth. The region shows the highest growth rate, projected to expand at a CAGR of 8.2% from 2021 to 2028.
- Middle East & Africa: The Middle East & Africa region holds a market share of 10.2%. Growth is driven by increasing healthcare investments and rising awareness of dietary supplements. However, market penetration remains lower compared to other regions.
- Latin America: Latin America has an 8.1% market share. Growing interest in natural and organic supplements and improving economic conditions support market growth. However, regulatory challenges and lower consumer awareness present hurdles.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The Bromelain market features several key players that significantly impact its dynamics through strategic positioning and market influence. Companies such as Antozyme Biotech Pvt Ltd., Biolaxi Corporation, and Creative Enzymes leverage their expertise in enzyme technology to develop high-quality Bromelain products. ENZYBEL GROUP and Advanced Enzyme Technologies stand out with robust research and development capabilities, ensuring innovative solutions and maintaining a competitive edge.
Mitushi Biopharma and Ursapharm Arzneimittel GmbH focus on pharmaceutical applications, expanding Bromelain’s use in healthcare. Meanwhile, Botanic Healthcare and Guangxi Nanning Javely Biological Products Co. emphasize natural and organic production processes, catering to the growing consumer demand for clean-label products.
Undersun Biomedtech Co., Ltd. and Dayang Chem (Hangzhou) Co. Ltd. play pivotal roles in the Asian market, capitalizing on regional growth opportunities. Enzyme Technology (PTY) Ltd. and Hong Mao Biochemicals Co., Ltd. contribute to market diversification with their extensive product portfolios.
These companies collectively enhance the market through continuous innovation, strategic collaborations, and targeted marketing. Their efforts not only drive market growth but also set industry standards for quality and efficacy. The combined influence of these key players ensures a dynamic and competitive Bromelain market landscape.
Market Key Players
- Antozyme Biotech Pvt Ltd.
- Biolaxi Corporation
- Biozym Gesellschaft fur Enzymtechnologie mbH
- Creative Enzymes
- ENZYBEL GROUP
- Mitushi Biopharma
- Advanced Enzyme Technologies
- Undersun Biomedtech Co., Ltd
- Dayang Chem (Hangzhou) Co., Ltd
- Enzyme Technology (PTY) Ltd.
- Guangxi Nanning Javely Biological Products Co.
- Hong Mao Biochemicals Co., Ltd.
- Ursapharm Arzneimittel GmbH
- Botanic Healthcare
Recent Developments
- January 2023: Sun Pharma Acquiring Disperzyme and Phlogam Brands Sun Pharma acquired three brands, Disperzyme, Disperzyme-CD, and Phlogam, from Aksigen Hospital Care. These brands are fixed-dose combinations of proteolytic enzymes and bioflavonoids, approved by the Drugs Controller General of India (DCGI) for post-operative inflammation in patients undergoing minor surgery and dental procedures.
- December 2022: Israeli Pineapple-Based Burn Treatment Heads to Japan MediWound’s non-surgical burn treatment, NexoBrid, enriched with bromelain, is entering the Japanese market. The treatment removes dead tissue from severe burns within four hours and prevents wound deterioration and scarring. Kaken Pharmaceutical will exclusively market and distribute NexoBrid in Japan starting in summer 2023.
Report Scope
Report Features Description Market Value (2023) USD 34.7 Million Forecast Revenue (2033) USD 63.9 Million CAGR (2024-2033) 6.3% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Product Type (Stem Bromelain, Fruit Bromelain), By Form (Powder, Liquid), By Application (Healthcare, Food & Beverage, Dietary Supplements, Cosmetics & Personal Care, Others) Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Antozyme Biotech Pvt Ltd., Biolaxi Corporation, Biozym Gesellschaft fur Enzymtechnologie mbH, Creative Enzymes, ENZYBEL GROUP, Mitushi Biopharma, Advanced Enzyme Technologies, Undersun Biomedtech Co.,Ltd, Dayang Chem (Hangzhou) Co. Ltd, Enzyme Technology (PTY) Ltd., Guangxi Nanning Javely Biological Products Co., Hong Mao Biochemicals Co., Ltd., Ursapharm Arzneimittel GmbH, Botanic Healthcare Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Frequently Asked Questions (FAQ)
What is the current market size of the Global Bromelain Market?The Global Bromelain Market was valued at USD 34.7 million in 2023. The market is projected to grow at a CAGR of 6.3% during the forecast period from 2024 to 2033.
Which region dominates the Bromelain Market?North America dominates the market with a 35.6% share.
Which key players are influential in the Bromelain Market?Key players include Antozyme Biotech Pvt Ltd., Biolaxi Corporation, Creative Enzymes, and ENZYBEL GROUP, among others.
What opportunities exist for growth in the Bromelain Market?Growth opportunities include the expansion of e-commerce platforms and the sports nutrition market.
- Antozyme Biotech Pvt Ltd.
- Biolaxi Corporation
- Biozym Gesellschaft fur Enzymtechnologie mbH
- Creative Enzymes
- ENZYBEL GROUP
- Mitushi Biopharma
- Advanced Enzyme Technologies
- Undersun Biomedtech Co., Ltd
- Dayang Chem (Hangzhou) Co., Ltd
- Enzyme Technology (PTY) Ltd.
- Guangxi Nanning Javely Biological Products Co.
- Hong Mao Biochemicals Co., Ltd.
- Ursapharm Arzneimittel GmbH
- Botanic Healthcare
- settingsSettings
Our Clients
Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |